Association of stroke with the receptor-binding profiles of antipsychotics - A case-crossover study

Biological Psychiatry

Volumn 73, Issue 5, 2013, Pages 414-421

  Wu, Chi Shin ^a,b,c   Wang, Sheng Chang ^d   Gau, Susan Shur Fen ^b,c   Tsai, Hui Ju ^d,e   Cheng, Yu Cheng ^d  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Antipsychotics; case crossover; dementia; dose related relationship; receptor binding profiles; stroke

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; AMISULPRIDE; ARIPIPRAZOLE; CHLORPROMAZINE; CHLORPROTHIXENE; CLOPENTHIXOL; CLOTIAPINE; CLOZAPINE; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; LEVOMEPROMAZINE; LOXAPINE; MELITRACEN; MOPERONE; MUSCARINIC M1 RECEPTOR; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; PIMOZIDE; PROCHLORPERAZINE; QUETIAPINE; RISPERIDONE; SULPIRIDE; THIORIDAZINE; TIOTIXENE; TRIFLUOPERAZINE; ZIPRASIDONE; ZOTEPINE;

ADULT; AGED; ARTICLE; BINDING AFFINITY; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CROSSOVER PROCEDURE; DEMENTIA; DRUG EXPOSURE; DRUG RECEPTOR BINDING; DRUG USE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; TAIWAN; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; BRAIN ISCHEMIA; CROSS-OVER STUDIES; DATABASES, FACTUAL; DEMENTIA; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; RISK; STROKE; TAIWAN;

EID: 84873716475     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2012.07.006     Document Type: Article

References (45)

1. World Health Organization The Atlas of Heart Disease and Stroke 2007 World Health Organization Geneva
2. H.C. Lin, Y.J. Lin, T.C. Liu, C.S. Chen, and W.T. Chiu Urbanization and stroke prevalence in Taiwan: Analysis of a nationwide survey J Urban Health 84 2007 604 614
3. H.H. Hu, W.Y. Sheng, F.L. Chu, C.F. Lan, and B.N. Chiang Incidence of stroke in Taiwan Stroke 23 1992 1237 1241
4. Health Statistics. Department of Health Executive Yuan, Taiwan Standardize Death Rates from Leading Causes of Death 2007 http://www.doh.gov.tw/ CHT2006/DM/DM2-2.aspx?now-fod-list-no=10327&class-no=440&level-no=4
5. R. Paulose-Ram, M.A. Safran, B.S. Jonas, Q. Gu, and D. Orwig Trends in psychotropic medication use among U.S. adults Pharmacoepidemiol Drug Saf 16 2007 560 570
6. I.C. Chien, S.H. Bih, Y.J. Chou, C.H. Lin, W.G. Lee, and P. Chou Trends in the use of psychotropic drugs in Taiwan: A population-based national health insurance study, 1997-2004 Psychiatr Serv 58 2007 554 557
7. E. Wooltorton Risperidone (Risperdal): Increased rate of cerebrovascular events in dementia trials CMAJ 167 2002 1269 1270
8. N. Herrmann, M. Mamdani, and K.L. Lanctot Atypical antipsychotics and risk of cerebrovascular accidents Am J Psychiatry 161 2004 1113 1115
9. V. Mittal, L. Kurup, D. Williamson, S. Muralee, and R.R. Tampi Risk of cerebrovascular adverse events and death in elderly patients with dementia when treated with antipsychotic medications: A literature review of evidence Am J Alzheimers Dis Other Demen 26 2011 10 28
10. E. Sacchetti, C. Turrina, and P. Valsecchi Cerebrovascular accidents in elderly people treated with antipsychotic drugs: A systematic review Drug Saf 33 2010 273 288
11. N. Herrmann, and K.L. Lanctot Do atypical antipsychotics cause stroke? CNS Drugs 19 2005 91 103
12. L.S. Schneider, K. Dagerman, and P.S. Insel Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomized, placebo-controlled trials Am J Geriatr Psychiatry 14 2006 191 210
13. L.A. Kryzhanovskaya, D.V. Jeste, C.A. Young, J.P. Polzer, T.E. Roddy, and J.F. Jansen A review of treatment-emergent adverse events during olanzapine clinical trials in elderly patients with dementia J Clin Psychiatry 67 2006 933 945
14. P.P. De Deyn, I.R. Katz, H. Brodaty, B. Lyons, A. Greenspan, and A. Burns Management of agitation, aggression, and psychosis associated with dementia: A pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone Clin Neurol Neurosurg 107 2005 497 508
15. N. Black Why we need observational studies to evaluate the effectiveness of health care BMJ 312 1996 1215 1218
16. R.B. D'Agostino Jr, and R.B. D'Agostino Sr Estimating treatment effects using observational data JAMA 297 2007 314 316
17. I.J. Douglas, and L. Smeeth Exposure to antipsychotics and risk of stroke: Self controlled case series study BMJ 337 2008 a1227
18. B.C. Kleijer, R.J. van Marum, A.C. Egberts, P.A. Jansen, W. Knol, and E.R. Heerdink Risk of cerebrovascular events in elderly users of antipsychotics J Psychopharmacol 23 2009 909 914
19. M. Percudani, C. Barbui, I. Fortino, M. Tansella, and L. Petrovich Second-generation antipsychotics and risk of cerebrovascular accidents in the elderly J Clin Psychopharmacol 25 2005 468 470
20. E. Sacchetti, G. Trifiro, A. Caputi, C. Turrina, E. Spina, and C. Cricelli Risk of stroke with typical and atypical anti-psychotics: A retrospective cohort study including unexposed subjects J Psychopharmacol 22 2008 39 46
21. L. Laredo, E. Vargas, A.J. Blasco, M.D. Aguilar, A. Moreno, and A. Portoles Risk of cerebrovascular accident associated with use of antipsychotics: Population-based case-control study J Am Geriatr Soc 59 2011 1182 1187
22. M.J. Barnett, H. Wehring, and P.J. Perry Comparison of risk of cerebrovascular events in an elderly VA population with dementia between antipsychotic and nonantipsychotic users J Clin Psychopharmacol 27 2007 595 601
23. M.C. Chan, C.S. Chong, A.Y. Wu, K.C. Wong, E.L. Dunn, O.W. Tang, and W.F. Chan Antipsychotics and risk of cerebrovascular events in treatment of behavioural and psychological symptoms of dementia in Hong Kong: A hospital-based, retrospective, cohort study Int J Geriatr Psychiatry 25 2010 362 370
24. R. Liperoti, G. Gambassi, K.L. Lapane, C. Chiang, C. Pedone, V. Mor, and R. Bernabei Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics J Clin Psychiatry 66 2005 1090 1096
25. E. Sacchetti, C. Turrina, B. Cesana, and G. Mazzaglia Timing of stroke in elderly people exposed to typical and atypical antipsychotics: A replication cohort study after the paper of Kleijer, et al J Psychopharmacol 24 2009 1131 1132
26. E. Richelson Receptor pharmacology of neuroleptics: Relation to clinical effects J Clin Psychiatry 60 suppl 10 1999 5 14
27. B.L. Roth, E. Lopez, S. Beischel, R.B. Westkaemper, and J.M. Evans Screening the receptorome to discover the molecular targets for plant-derived psychoactive compounds: A novel approach for CNS drug discovery Pharmacol Ther 102 2004 99 110
28. W.K. Kroeze, S.J. Hufeisen, B.A. Popadak, S.M. Renock, S. Steinberg, and P. Ernsberger H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs Neuropsychopharmacology 28 2003 519 526
29. D. Layton, S. Harris, L.V. Wilton, and S.A. Shakir Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia J Psychopharmacol 19 2005 473 482
30. S. Finkel, C. Kozma, S. Long, A. Greenspan, R. Mahmoud, O. Baser, and L. Engelhart Risperidone treatment in elderly patients with dementia: Relative risk of cerebrovascular events versus other antipsychotics Int Psychogeriatr 17 2005 617 629
31. S.S. Gill, P.A. Rochon, N. Herrmann, P.E. Lee, K. Sykora, and N. Gunraj Atypical antipsychotic drugs and risk of ischaemic stroke: Population based retrospective cohort study BMJ 330 2005 445
32. M. Maclure The case-crossover design: A method for studying transient effects on the risk of acute events Am J Epidemiol 133 1991 144 153
33. S. Schneeweiss, T. Sturmer, and M. Maclure Case-crossover and case-time-control designs as alternatives in pharmacoepidemiologic research Pharmacoepidemiol Drug Saf 6 suppl 3 1997 S51 S59
34. C.S. Wu, S.C. Wang, Y.C. Cheng, and S.S. Gau Association of cerebrovascular events with antidepressant use: A case-crossover study Am J Psychiatry 168 2011 511 521
35. World Health Organization Collaborating Centre for Drug Statistics Guidelines for ATC Classification and DDD Assignment 2009 World Health Organization Oslo
36. D.M. Gardner, A.L. Murphy, H. O'Donnell, F. Centorrino, and R.J. Baldessarini International consensus study of antipsychotic dosing Am J Psychiatry 167 2010 686 693
37. R.A. Deyo, D.C. Cherkin, and M.A. Ciol Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 1992 613 619
38. S. Guimaraes, and D. Moura Vascular adrenoceptors: An update Pharmacol Rev 53 2001 319 356
39. O.G. Cameron, J.K. Zubieta, L. Grunhaus, and S. Minoshima Effects of yohimbine on cerebral blood flow, symptoms, and physiological functions in humans Psychosom Med 62 2000 549 559
40. A. Elhusseiny, Z. Cohen, A. Olivier, D.B. Stanimirovic, and E. Hamel Functional acetylcholine muscarinic receptor subtypes in human brain microcirculation: Identification and cellular localization J Cereb Blood Flow Metab 19 1999 794 802
41. S. Singh, Y.K. Loke, and C.D. Furberg Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis JAMA 300 2008 1439 1450
42. G.C. Roman, T. Erkinjuntti, A. Wallin, L. Pantoni, and H.C. Chui Subcortical ischaemic vascular dementia Lancet Neurol 1 2002 426 436
43. H.C. Lin, F.H. Hsiao, S. Pfeiffer, Y.T. Hwang, and H.C. Lee An increased risk of stroke among young schizophrenia patients Schizophr Res 101 2008 234 241
44. C.L. Cheng, Y.H. Kao, S.J. Lin, C.H. Lee, and M.L. Lai Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan Pharmacoepidemiol Drug Saf 20 2011 236 242
45. P.L. Kolominsky-Rabas, M. Weber, O. Gefeller, B. Neundoerfer, and P.U. Heuschmann Epidemiology of ischemic stroke subtypes according to TOAST criteria: Incidence, recurrence, and long-term survival in ischemic stroke subtypes: A population-based study Stroke 32 2001 2735 2740